Atlas Trials

Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma

Clinical trial NCT01677468 · UNKNOWN

Trial details

NCT number
NCT01677468
Sponsor
Hallym University Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular CarcinomaTransarterial Chemoembolization
Start date
2012-08-01
Primary completion
2015-07-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.